AnnouncementSep 2026
Sep 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 22 Sep - Management to join Arihant Capital Bharat Connect virtual conference on 28 September 2026, 4-5 pm.
Source: Bse
Meghmani Organics Limited (MOL)
Small CapIndustrials stocks · Small cap · NSE
Meghmani Organics Limited operates in Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.
Data qualityFresh enough for analysisQuote updated 19 Oct, 05:50 pm ISTDetails
Quote19 Oct, 05:50 pm IST
Base fundamentals18 Oct 2026 · screener
Latest result29 Jul, 06:49 pm IST
Score20 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags03 May 2026
Coverage14/14 · 100%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens
Trend score and candlestick chart
47NeutralSMA20 -7.2% / mo · MACD −
Stock trend: 45
Sector RS: 50
Sector 3M: -6.3% vs Nifty 500 -5.6%
Industrials FPI tailwindNot confirmed
Latest mapped FPI equity flow was not positive. View sector evidence
Technical chart
MOLD candles · FIT view+7.8%Latest close ₹56.59 on 2026-10-19
Bar
-4.2%
RSI
44
MACD hist
-0.02
52W pos
43%
2026-10-19O ₹59.05H ₹59.05L ₹56.10C ₹56.59Vol 12.5L sh
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context
Relative performance and chart statistics
Adjusted completed-session prices, rebased to 100
MOLNifty India ManufacturingNifty 500
- MOL
- +11.6%
- Nifty 500
- -5.6%
- Nifty India Manufacturing
- -5.8%
- Vs Nifty 500
- +17.1 pp
Chart stats
19 Oct 2026- From 52W high
- -32.2%
- 52W range position
- 43%
- ATR (14)
- 5.5%
- Volume vs 20D
- 1.67x
- Avg traded value
- ₹4.3 Cr
- 20D price channel
- ₹53.3 - ₹64.4
₹83.5
₹36.5 - ₹83.5
₹3.1
Latest completed session
20-session average
52.3% annualized volatility
Research snapshot
What the evidence says now
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.
Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
Legacy · OVERVALUED31
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Latest result
Average50
Revenue -11.6% · PAT +269.2% YoY
Technical
Neutral47
Price trend and sector-relative-strength timing.
Valuation
Legacy model-1349.0%
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Trust
Limited evidence66
Financial-only signal; management claim evidence is not sufficient yet.
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Latest result
Quarter ended 30 Jun 2026
Average · 50/100Rev -12% YoY · PAT +269% YoY · margin expansion · +15% QoQ · operating leverage
Filed 29 Jul 2026
Open results browser →| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹543 Cr | -11.6% | +14.6% |
| EBITDA | ₹98 Cr | +46.3% | +390.0% |
| Operating margin | 18.0% | +700 bps | +1380 bps |
| PAT | ₹48 Cr | +269.2% | +500.0% |
| PAT margin | 8.8% | +672 bps | +715 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Fundamentals
Valuation
- P/E
- 23.60
- P/B
- 0.98
- EV/EBITDA
- 6.87
- Market Cap
- 1514.00Cr
Profitability
- ROE
- 1.90%
- ROCE
- 6.71%
- ROA
- 2.12%
- Dividend Y
- —
Growth (CAGR)
- Revenue 5Y
- 6.00%
- EPS 5Y
- -31.00%
- Revenue 3Y
- -5.00%
- EPS 3Y
- -49.00%
Balance Sheet
- Debt/Equity
- 0.47
- Interest Coverage
- 2.76×
- Altman Z
- 2.43
- Book Value
- 60.70
Cash Flow
- FCF Yield
- 12.15%
- FCF Positive Y
- 5/5
- OCF
- 222.00 Cr
- EPS TTM
- 2.52
Shareholding
- Promoter Hold
- 48.95%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 49%
Financial History
Updated 19/10/2026
Revenue
₹ CrLatest: 543+14.6% vs prev
Net Profit
₹ CrLatest: 48.0+500.0% vs prev
ROE is shown only in the Annual view — quarterly equity data isn't published.
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Daily technical trend read
Bearish setupTrend is weak — long-term uptrend intact. RSI 44.
- Price above SMA200 (long-term uptrend) but mid-term MAs not aligned.
- SMA20 falling (~7.8% over last month) — short-term momentum negative.
- RSI(14) at 44 — sideways, no extreme reading.
- MACD below signal, histogram expanding negatively — bearish momentum building.
- 32% off 52W high · 55% above 52W low.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Nifty 500 leadership
Relative Strength & Trend Stage
46
RS percentile
Stage 2 UptrendEstablished S2
1M return
-10.2%
3M return
+11.6%
6M return
+5.0%
1Y return
-29.9%
RS 1D
-7
RS 20D
-17
Sector rank
#2
Industry rank
#9
Stage evidence
- Price is 6.1% above the 30-week proxy.
- The 50-DMA is above the 30-week proxy and its slope is rising +2.8%.
- Both 3-month and 6-month returns are positive.
50-DMA
price below
200-DMA
price above
S2 entered
02 Sept 2026
S2 age
32 trading sessions
Sector
leading
Industry
leading
Relative-strength line vs Nifty 500 (base 100)
262 observations
19 Oct 2026Value 72.11-3.98%
RS vs Nifty 50072
Valuation & peers
U-Score 31 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Valuation & peers
U-Score 31 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
OVERVALUED
Fundamental score breakdown
U band · OVERVALUEDValuation8/30
Growth3/25
Quality0/20
Balance Sheet7/15
Cash Flow10/10
Piotroski
6/9 (+3)
Penalties
0
Raw sum
31
Why this score?
Top U-Score contributors and drags from the latest stored fundamentals.
31/100 · legacy band OVERVALUED
Positive drivers
- FCF yield is supportive at 12.2%.
- Cash flow contributes 10/10 to the score.
- Balance sheet contributes 7/15 to the score.
Main drags
- Fair-value margin of safety is negative at -1349.0%.
- Quality is weaker at 0/20; verify the latest quarterly trend.
- Growth is weaker at 3/25; verify the latest quarterly trend.
Sector valuation model
Cyclical valuation: normalized earnings, not just trailing PE
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
23.6
PB
1.0
EV/EBITDA
6.9
ROE
1.9%
ROCE
6.7%
FCF Yield
12.2%
Debt/Equity
0.5
MoS
-1349.0%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Stored run: 20 Oct 2026
v4.3-runtime-valuation
Final score
31
Previous: 31
Legacy U-Score band
OVERVALUED
Previous: OVERVALUED
Margin of safety
-1349.0%
Previous: -1349.0%
Score history
12 stored score snapshots. Latest stored move: +2 points.
20 Oct 2026
v4.3-runtime-valuation
31
30
30
30
31
30
31
31
29
29
29
31
Factor attribution
No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Modelled fair value
Graham Number
₹58.67
+3.5% MoS
Growth-justified P/E
1.6
Growth-justified Value
₹3.91
-1349.0% MoS
PEG
—
Comparable companies
Peers
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
MWL
Small
Mangalam Worldwide Limited
Specialty Chemicals
match 164
55
21.5
18.0%
+44%
FAIR VALUE
SADHNANIQ
Small
Sadhana Nitrochem Limited
Specialty Chemicals
match 162
18
—
-23.5%
—
OVERVALUED
OCCLLTD
Small
OCCL Limited
Specialty Chemicals
match 162
63
12.9
12.2%
+68%
UNDERVALUED
UNIENTER
Small
Uniphos Enterprises Limited
Specialty Chemicals
match 162
33
29.6
0.8%
-405%
WATCHLIST
DCW
Small
DCW Limited
Specialty Chemicals
match 161
15
—
-0.7%
—
OVERVALUED
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business and thesis
Issuer presentation review pending
Meghmani Organics Limited operates in Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 30 Jun 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.
Trust Score
66Limited evidence · low confidenceTrust Lite
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 49th percentile of the scored universe and 47th percentile within Industrials. Main check: results consistency is weak at 36/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Computed 05 Sept 2026
management-trust-v1
87 docs text-extracted · 40 concalls text-extracted
Score band
Limited evidence
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
Relative rank
49th percentile
overall median 67 · Industrials: 47th pctile, median 68 · Small: 54th pctile, median 66
Evidence depth
Financial-only
87 documents have extracted text, but claim history is not strong enough yet.
Claim delivery
Outcome history still building
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Limited evidence · low confidenceWhat it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Promoter
78
strong · holding, pledge, alignment
Cash flow
89
strong · profit to cash conversion
Balance sheet
73
acceptable · leverage and solvency
Discipline
40
weak · capital discipline
Results
36
weak · quarterly consistency
Trust positives
- ▸Promoter pledge is zero.
- ▸FCF yield is 10.9%.
- ▸5 years of positive FCF.
Trust risks
- ▸ROCE is low at 6.7%.
- ▸ROE is low at 1.9%.
- ▸1/4 latest quarters had positive YoY revenue growth.
- ▸1 of the latest 4 quarters had PAT decline worse than 25% YoY.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Continue researching Meghmani Organics Limited
Important announcements & filings
Latest exchange and company disclosures found within the past two years.
Open source ↗
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 2 Sep
Source: Bse
Concall transcriptAug 2026
Aug 2026 · Transcript
Source: Bse
Investor presentationAug 2026
Aug 2026 · PPT
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 15 Aug - Newspaper Advertisement pertaining to 7th AGM of the Company
Source: Bse
Concall transcriptMay 2026
May 2026 · Transcript
Source: Bse
Investor presentationMay 2026
May 2026 · PPT
Source: Bse
Investor presentationMay 2026
May 2026 · PPT
Source: Bse
Concall transcriptMay 2026
May 2026 · Transcript
Source: Bse
Concall transcriptMay 2026
May 2026 · Transcript
Source: Bse
Annual report
Annual Report 2026
Source: Bse
Annual report
Annual Report 2026 from bse
Source: Bse
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.